Provided by Tiger Trade Technology Pte. Ltd.

Anaptysbio Inc

57.40
-7.5900-11.68%
Post-market: 58.240.8400+1.46%19:40 EDT
Volume:1.35M
Turnover:79.83M
Market Cap:1.65B
PE:-124.75
High:66.28
Open:65.16
Low:55.61
Close:64.99
52wk High:68.39
52wk Low:15.40
Shares:28.75M
Float Shares:17.26M
Volume Ratio:2.56
T/O Rate:7.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4601
EPS(LYR):-0.4601
ROE:-24.49%
ROA:7.06%
PB:44.35
PE(LYR):-124.75

Loading ...

Wedbush Raises Price Target on AnaptysBio to $75 From $60, Keeps Outperform Rating

MT Newswires Live
·
Mar 12

Stock Track | AnaptysBio Soars 5.23% Intraday After Truist Securities Raises Price Target

Stock Track
·
Mar 09

AnaptysBio Is Maintained at Hold by Truist Securities

Dow Jones
·
Mar 09

Truist Financial Keeps Their Hold Rating on AnaptysBio (ANAB)

TIPRANKS
·
Mar 09

U.S. RESEARCH ROUNDUP-Dow, Oracle, Shopify

Reuters
·
Mar 09

Truist Adjusts Price Target on AnaptysBio to $50 From $36, Maintains Hold Rating

MT Newswires Live
·
Mar 06

Stock Track | AnaptysBio Plummets 5.37% Intraday as Risks from Proposed Breakup Weigh on Shares

Stock Track
·
Mar 05

Analysts’ Top Healthcare Picks: Oculis Holding (OCS), AnaptysBio (ANAB)

TIPRANKS
·
Mar 05

U.S. RESEARCH ROUNDUP-Broadcom, CNX Resources, Veeva Systems

Reuters
·
Mar 05

Risks Loom for AnaptysBio’s Proposed Breakup: Market Value, Volatility and Execution Challenges Highlighted

TIPRANKS
·
Mar 05

AnaptysBio Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 05

BUZZ-U.S. STOCKS ON THE MOVE-AnaptysBio, Tesla, Intel

Reuters
·
Mar 05

BUZZ-AnaptysBio climbs on plans to split into two public companies

Reuters
·
Mar 05

AnaptysBio Is Maintained at Overweight by Barclays

Dow Jones
·
Mar 04

Stock Track | Anaptysbio Soars 6.15% Intraday on Multiple Analyst Target Price Hikes

Stock Track
·
Mar 04

AnaptysBio Inc : Wedbush Raises Target Price to $60 From $50

THOMSON REUTERS
·
Mar 04

AnaptysBio Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 04

Wedbush Raises Price Target on AnaptysBio to $60 From $50, Keeps Outperform Rating

MT Newswires Live
·
Mar 04

AnaptysBio : Barclays Raises Target Price to $79 From $78

THOMSON REUTERS
·
Mar 04

AnaptysBio price target raised to $66 from $51 at H.C. Wainwright

TIPRANKS
·
Mar 04